XML 102 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisitions (Details) - USD ($)
 1 Months Ended 9 Months Ended 12 Months Ended
Aug. 07, 2019
Mar. 18, 2019
Mar. 31, 2019
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Jan. 29, 2021
Mar. 01, 2019
Asset Acquisition [Line Items]                  
Period during which share transfer is restricted     18 months            
Period during which the shares may be exchanged     60 days            
In process research and development costs expensed         $ 0 $ 0 $ 75,301,000    
As Restated [Member]                  
Asset Acquisition [Line Items]                  
Accrued Liabilities $ 400,000                
Sorrento [Member] | 2022 Promissory Note [Member]                  
Asset Acquisition [Line Items]                  
Debt Instrument, Face Amount       $ 5,000,000          
Notes Payable, Related Parties       $ 4,100,000          
Debt instrument, term       7 years          
Debt Instrument, Interest Rate, Stated Percentage       2.66%          
Senmur [Member]                  
Asset Acquisition [Line Items]                  
Asset acquisition total consideration transferred   $ 70,000,000              
Payments to acquire productive assets   15,000,000              
Asset acquistion consideration transferred equity interest issued and issuable   $ 55,000,000              
Stock issued during period shares purchase of assets   47,039,315              
Common stock shares subscribed but not issued 352,972 352,972              
Asset acquisition price per share $ 1.16 $ 1.16              
Percentage of ownership interest   58.00%              
Asset acquistion contingent consideration   $ 280,000,000   $ 0 $ 0 $ 0      
Percentage of shares issued subject to restriction of transfer                 100.00%
Period during which share transfer is restricted     18 months            
Period during which the shares may be exchanged     60 days            
Common stock value to be exchanged     $ 55,000,000            
Number of days for determining the weighted volume averge price of shares     30 days            
Price per share for determining the exchange of shares                 $ 5.55
Payment made in surrendering the shares     $ 55,000,000            
In process research and development costs expensed             $ 75,300,000    
Proceeds from Divestiture of Businesses $ 40,000,000                
Senmur [Member] | As Restated [Member]                  
Asset Acquisition [Line Items]                  
Accrued Liabilities $ 400,000                
Senmur [Member] | Sorrento [Member]                  
Asset Acquisition [Line Items]                  
Payment made in surrendering the shares     $ 55,000,000            
Percentage of shares outstanding           82.30%   99.97%  
Senmur [Member] | Regulatory Based Milestone [Member]                  
Asset Acquisition [Line Items]                  
Asset acquistion contingent consideration   40,000,000              
Senmur [Member] | Reveue Based Milestone [Member] | Tranche 1 [Member]                  
Asset Acquisition [Line Items]                  
Asset acquistion contingent consideration   20,000,000              
Revenue to be earned by the acquiree value   100,000,000              
Senmur [Member] | Reveue Based Milestone [Member] | Tranche 2 [Member]                  
Asset Acquisition [Line Items]                  
Asset acquistion contingent consideration   20,000,000              
Revenue to be earned by the acquiree value   250,000,000              
Senmur [Member] | Reveue Based Milestone [Member] | Tranche 3 [Member]                  
Asset Acquisition [Line Items]                  
Asset acquistion contingent consideration   50,000,000              
Revenue to be earned by the acquiree value   500,000,000              
Senmur [Member] | Reveue Based Milestone [Member] | Tranche 4 [Member]                  
Asset Acquisition [Line Items]                  
Asset acquistion contingent consideration   150,000,000              
Revenue to be earned by the acquiree value   $ 750,000,000              
Aardvark [Member]                  
Asset Acquisition [Line Items]                  
Asset acquistion contingent consideration       0          
Aardvark [Member] | Reveue Based Milestone [Member]                  
Asset Acquisition [Line Items]                  
Asset acquistion contingent consideration       20,000,000          
Aardvark [Member] | Approval Based Milestone [Member]                  
Asset Acquisition [Line Items]                  
Asset acquistion contingent consideration       3,000,000          
Romeg License Agreement [Member]                  
Asset Acquisition [Line Items]                  
Asset acquistion contingent consideration       0          
Upfront License Fee       2,000,000          
Milestone payment       13,000,000          
Royalty payments       7,100,000          
Acquired Finite-Lived Intangible Asset, Residual Value       5,700,000          
Deferred consideration       $ 3,700,000          
Finite lived intangible asset, Useful life       15 years